Page last updated: 2024-11-03

protoporphyrin ix and Head and Neck Neoplasms

protoporphyrin ix has been researched along with Head and Neck Neoplasms in 5 studies

protoporphyrin IX: RN given refers to parent cpd; structure in Merck Index, 9th ed, #7685
protoporphyrin : A cyclic tetrapyrrole that consists of porphyrin bearing four methyl substituents at positions 3, 8, 13 and 17, two vinyl substituents at positions 7 and 12 and two 2-carboxyethyl substituents at positions 2 and 18. The parent of the class of protoporphyrins.

Head and Neck Neoplasms: Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651)

Research Excerpts

ExcerptRelevanceReference
"Head and neck squamous cell carcinomas (HNSCC) have a high mortality rate, although several potential therapeutic targets have already been identified."1.51Suitability of GnRH Receptors for Targeted Photodynamic Therapy in Head and Neck Cancers. ( Brauswetter, D; Csík, G; Gurbi, B; Halmos, G; Mező, G; Murányi, J; Pénzes, K; Pethő, L, 2019)
"Human head and neck cancer cells AMC-HN3 were treated with cisplatin- and ALA-mediated PDT individually, and also in combination."1.40Cisplatin enhances the efficacy of 5-aminolevulinic acid mediated photodynamic therapy in human head and neck squamous cell carcinoma. ( Ahn, JC; Biswas, R; Chung, PS; Lee, YK; Mondal, A, 2014)
" We have investigated the effect of 5-ALA mediated PDT in combination with gamma-irradiation on the colony forming ability of several human head and neck tumour cell lines."1.31Effect of photodynamic therapy in combination with ionizing radiation on human squamous cell carcinoma cell lines of the head and neck. ( Allman, R; Cowburn, P; Mason, M, 2000)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pethő, L1
Murányi, J1
Pénzes, K1
Gurbi, B1
Brauswetter, D1
Halmos, G1
Csík, G1
Mező, G1
Ahn, JC1
Biswas, R1
Mondal, A1
Lee, YK1
Chung, PS1
Liutkeviciūte-Navickiene, J1
Mordas, A1
Simkute, S1
Bloznelyte-Plesniene, L1
Wang, I1
Clemente, LP1
Pratas, RM1
Cardoso, E1
Clemente, MP1
Montán, S1
Svanberg, S1
Svanberg, K1
Allman, R1
Cowburn, P1
Mason, M1

Other Studies

5 other studies available for protoporphyrin ix and Head and Neck Neoplasms

ArticleYear
Suitability of GnRH Receptors for Targeted Photodynamic Therapy in Head and Neck Cancers.
    International journal of molecular sciences, 2019, Oct-11, Volume: 20, Issue:20

    Topics: Adult; Aged; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor;

2019
Cisplatin enhances the efficacy of 5-aminolevulinic acid mediated photodynamic therapy in human head and neck squamous cell carcinoma.
    General physiology and biophysics, 2014, Volume: 33, Issue:1

    Topics: Aminolevulinic Acid; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cel

2014
[Fluorescence diagnostics of skin tumors using 5-aminolevulinic acid and its methyl ester].
    Medicina (Kaunas, Lithuania), 2009, Volume: 45, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Carcinoma, Squamous Cell

2009
Fluorescence diagnostics and kinetic studies in the head and neck region utilizing low-dose delta-aminolevulinic acid sensitization.
    Cancer letters, 1999, Jan-08, Volume: 135, Issue:1

    Topics: Administration, Oral; Adult; Aged; Aminolevulinic Acid; Dose-Response Relationship, Drug; Endoscopy;

1999
Effect of photodynamic therapy in combination with ionizing radiation on human squamous cell carcinoma cell lines of the head and neck.
    British journal of cancer, 2000, Volume: 83, Issue:5

    Topics: Aminolevulinic Acid; Carcinoma, Squamous Cell; Cell Cycle; Cell Survival; Combined Modality Therapy;

2000